|
She will be joining the laboratory on January 10th, 2012 moving from the laboratory of Zachary Bulman at the University of Illinois at Chicago. Yanqin comes with great experience in pharmaceutical antimicrobial development.
Just posted to MedRXiv. Our collaborative study (Harvard School of Public Health and Beth Israel Deaconess Medical Center) supports the use of SARS-CoV-2 antigen tests for identifying individuals who are infectious at the time of testing.
We are grateful to the Massachusetts Life Sciences Center which provided funding for the investigation through an Accelerating Coronavirus Testing Solutions Grant  Pyocyanin (blue) + pyoverdin siderophore (yellow) --> green especially in cation adjusted mueller hinton broth as shown as demonstrated by a new laboratory member.
May 13th 11 am EST. Here is the link. I am still focused on Gram-negative pathogens. There has been a "small" diversion to address time-sensitive clinical issues.
April 28th, via Zoom in lieu of traditional meet at the Publick House, Sturbridge, MA. Alex will present amotosalen. I'll give an updated on our Mass Life Sciences Centers sponsored SARS-CoV-2 antigen study.
He just could not stay away. A one-month ultimate or penultimate medical student rotation prior to graduation to address some outstanding questions in antimicrobial resistance in the lab and write a review of the field (trival undertaking).
|
Kirby Lab Blog Categories
All
Archives
December 2021
|
RSS Feed